Jury Clears Exela In Blood Pressure Drug Patent Suit

A Delaware federal jury has cleared Exela Pharma Sciences in a suit claiming that its injection used to treat low blood pressure during anesthesia infringed patents owned by Nexus Pharmaceuticals....

Already a subscriber? Click here to view full article